Meeting
2019 Gastrointestinal Cancers Symposium
Phase I study of preoperative capecitabine and lenvatinib with external radiation therapy in locally advanced rectal adenocarcinoma.
Authors
Jessica Frakes
Moffitt Cancer Center, Tampa, FL
Jessica Frakes , Rutika Mehta , Sarah E. Hoffe , Iman Imanirad , Maria E Martinez Jimenez , Julian Sanchez , Mokenge Peter Malafa , Seth Felder , Sophie Dessureault , Richard D. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT02935309
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 694)
DOI
10.1200/JCO.2019.37.4_suppl.694
Abstract #
694
Poster Bd #
N19
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Phase I study of preoperative capecitabine and lenvatinib with external radiation therapy in locally advanced rectal adenocarcinoma.
First Author: Ankita Tandon
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prospective evaluation of dose-escalated preoperative concurrent chemo-radiation with image-guided intensity modulated radiation therapy in locally advanced rectal cancers.
First Author: Raunaq Puri
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Nivolumab and a CCR2/CCR5 dual antagonist (BMS-813160) with or without GVAX for locally advanced pancreatic ductal adenocarcinomas: Results of phase I study.
First Author: Eric Christenson
Poster
2022 ASCO Annual Meeting
A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma.
First Author: Sujana Movva